Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative BOTOX injection to prevent pancreatic fistula after distal pancreatectomy
NL-OMON60397Phase 2Completed
- Sponsor
- Erasmus MC
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in pancreatic fistula (POPF), sponsored by Erasmus MC. Primary endpoint: Feasibility and safety of preoperative endoscopic BOTOX injection in the sphincter of Oddi. Started Nov 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NL-OMON60397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60397.